retatrutide ly3437943 glp-1 gip glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide Phase 3: 28.7% Weight

In addition to weight loss, some GLP-1 medications can reduce cardiovascular risk and help treat conditions such as fatty liver disease and obstructive sleep apnea

The herbal supplement industry in general is not well regulated, Reierson points out

Tirzepatide is a dual GLP-1 and GIP receptor agonist - it activates two receptor types simultaneously

According to Sally Lyons Wyatt, Global EVP & Chief Advisor Consumer Goods & Foodservice Insights at Circana, LLC, food and beverage manufacturers are actively adapting their portfolios to account for the needs of these consumers

Needle Aversion: Individuals who have avoided GLP-1 therapy solely because they are afraid of needles or uncomfortable with self-injections

Hims & Hers has a clear growth roadmap, "leveraging both organic growth and strategic investments to expand category leadership and global reach," executives said